rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1999-3-12
|
pubmed:abstractText |
A hybrid protein [Met-Ala-(His)6OprF190-342-OprI21-83] consisting of the mature outer membrane protein I (OprI) and amino acids 190 to 342 of OprF of Pseudomonas aeruginosa was expressed in Escherichia coli and purified by Ni2+ chelate-affinity chromatography. After safety and pyrogenicity evaluations in animals, four groups of eight adult human volunteers were vaccinated intramuscularly three times at 4-week intervals and revaccinated 6 months later with either 500, 100, 50, or 20 microg of OprF-OprI adsorbed onto A1(OH)3. All vaccinations were well tolerated. After the first vaccination, a significant rise of antibody titers against P. aeruginosa OprF and OprI was measured in volunteers receiving the 100- or the 500-microg dose. After the second vaccination, significant antibody titers were measured for all groups. Elevated antibody titers against OprF and OprI could still be measured 6 months after the third vaccination. The capacity of the elicited antibodies to promote complement binding and opsonization could be demonstrated by a C1q-binding assay and by the in vitro opsonophagocytic uptake of P. aeruginosa bacteria. These data support the continued development of an OprF-OprI vaccine for use in humans.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-1438580,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-1706316,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-1940392,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-1984637,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-2114360,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-2210853,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-2447060,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-2449095,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-2502533,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-2511252,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-2602775,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-2833440,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-3033095,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-3102446,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-3110215,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-3121520,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-3131471,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-3924612,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-402473,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-6183370,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-6323316,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-6799548,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-7539410,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-7580798,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-7729895,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-7839727,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-8063415,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-8456293,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-8911006,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-9382752,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-9382754,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-9382760,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-9437483,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-9449262,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-9451928,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-9456102,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-9542905,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10024596-9673254
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0019-9567
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
67
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1461-70
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:10024596-Adult,
pubmed-meshheading:10024596-Antibodies, Bacterial,
pubmed-meshheading:10024596-Bacterial Proteins,
pubmed-meshheading:10024596-Bacterial Vaccines,
pubmed-meshheading:10024596-Female,
pubmed-meshheading:10024596-Humans,
pubmed-meshheading:10024596-Lipoproteins,
pubmed-meshheading:10024596-Male,
pubmed-meshheading:10024596-Phagocytosis,
pubmed-meshheading:10024596-Porins,
pubmed-meshheading:10024596-Pseudomonas aeruginosa,
pubmed-meshheading:10024596-Recombinant Fusion Proteins,
pubmed-meshheading:10024596-Vaccination,
pubmed-meshheading:10024596-Vaccines, Synthetic
|
pubmed:year |
1999
|
pubmed:articleTitle |
Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
|
pubmed:affiliation |
Chirurgische Universitätsklinik der Universität Freiburg, Freiburg, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|